https://www.marketscreener.com/quote/stock/GALMED-PHARMACEUTICALS-LT-16000956/news/FDA-Agrees-with-Galmed-s-Plan-to-use-Aramchol-Meglumine-in-the-Randomized-Double-Blind-Placebo-Contr-36052715/?utm_source=telegram&utm_medium=social&utm_campaign=share